Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
The Engineering Science MS with a course focus in Data Science offers students a comprehensive education in big data and analysis. Students gain knowledge, expertise, and practical training in various ...
Shares in Sanofi were sliding today after a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis (MS). Along with what looks set to be ...
*Monthly and annual subscriptions automatically renew and may be canceled at any time. All prices exclude taxes. See our Terms for more details. The go-to tool for appraisers seeking data that they ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
With countless CBD brands on the market today, you may be wondering where to begin. We did the research so you can make an informed decision on your next CBD purchase. Here, we share our picks of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results